UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000660
Receipt number R000000797
Scientific Title Development of new strategy for end stage dilated cardiomyopathy, a combination of left ventricular assist device and aoutologous myoblast sheets
Date of disclosure of the study information 2007/04/01
Last modified on 2021/01/27 09:47:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of new strategy for end stage dilated cardiomyopathy, a combination of left ventricular assist device and aoutologous myoblast sheets

Acronym

A combination of left ventricular assist device and aoutologous myoblast sheets for end stage dilated cardiomyopathy

Scientific Title

Development of new strategy for end stage dilated cardiomyopathy, a combination of left ventricular assist device and aoutologous myoblast sheets

Scientific Title:Acronym

A combination of left ventricular assist device and aoutologous myoblast sheets for end stage dilated cardiomyopathy

Region

Japan


Condition

Condition

End stage dilated cardiomyopathy patients who need LVAS

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Development of establishment of the methods utilizing aoutologous myoblast sheets cultured from skeletal muscle in the combination with left ventricular assist system (LVAS) against end stage dilated cardiomyopathy. The safety and the efficacy are tested.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Adverse events

Key secondary outcomes

Caridac function


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Device,equipment Behavior,custom
Maneuver

Interventions/Control_1

Culture of autologous skeltal myoblasts and engineering myoblast sheets. Transplantation of the myoblast sheets to the heart in the combination with LVAS implantation.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

End stage dilated cardiomyopathy
Requiring LVAS

Key exclusion criteria

Severe skeletal muscle disease
Cancer
Severe infection
Alcoholic or drug addiction in recent six months
Pregnancy
Others (doctors dicision)

Target sample size

6


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiki Sawa

Organization

Osaka University Graduate school of medicine

Division name

Cardiovascular surgery

Zip code


Address

2-2 Yamadaoka Suita city, Osaka

TEL

06-6879-3154

Email



Public contact

Name of contact person

1st name
Middle name
Last name Goro Matsumiya

Organization

Osaka University Graduate school of medicine

Division name

Cardiovascular surgery

Zip code


Address

2-2 Yamadaoka Suita city, Osaka

TEL

06-6879-3154

Homepage URL


Email

matsumg@surg1.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University Graduate school of medicine, Cardiovascular surgery

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2006 Year 09 Month 14 Day

Date of IRB


Anticipated trial start date

2007 Year 03 Month 01 Day

Last follow-up date

2008 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2007 Year 03 Month 29 Day

Last modified on

2021 Year 01 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000797


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name